AI heart tracing to guide potassium treatment in the ER
Part of Hormones & metabolism clinical trials.
This study looks at whether using an AI tool on ECG (heart tracing) can help doctors decide the best timing for giving medicine to lower high potassium levels in the emergency department. If you have high potassium, this could help guide your treatment to keep your heart safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in the emergency department.
- A recent blood test must show a potassium level of 5.5 or higher.
- An ECG (heart tracing) must have been done within 1 hour of that blood test.
- You should not have received any potassium-lowering treatment before that blood test.
- You should be starting a potassium-lowering treatment within 4 hours after the test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a portable ECG device can help detect high potassium levels early in people with moderate to severe chronic kidney disease. It aims to make monitoring easier without frequent blood tests.
This trial uses an AI program to review ECG heart-tracing data collected from short-term monitoring devices. It aims to see whether the AI can better detect concerning heart rhythm patterns in people who are high risk for heart rhythm or heart problems.
This study tests if a device can accurately measure potassium levels in people with chronic kidney disease. It also uses an iPhone app to monitor patients remotely.
This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.
This trial is testing whether using artificial intelligence to read ECGs in the emergency department helps doctors better manage heart attacks, especially under a new payment system. It may help speed up treatment and improve care.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
Hear when a new Hyperkalaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.